Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta …
BL Coleman, R Sanderson, MDM Haag… - Influenza and other …, 2021 - Wiley Online Library
Background Standard‐dose seasonal influenza vaccines often produce modest
immunogenic responses in adults≥ 65 years old. MF59 is intended to elicit a greater …
immunogenic responses in adults≥ 65 years old. MF59 is intended to elicit a greater …
Relative effectiveness of adjuvanted trivalent inactivated influenza vaccine versus egg-derived quadrivalent inactivated influenza vaccines and high-dose trivalent …
C Boikos, L Fischer, D O'Brien, J Vasey… - Clinical Infectious …, 2021 - academic.oup.com
Background The effectiveness of standard, egg-derived quadrivalent influenza vaccines
(IIV4) may be reduced in adults≥ 65 years of age, largely because of immunosenescence …
(IIV4) may be reduced in adults≥ 65 years of age, largely because of immunosenescence …
Relative effectiveness of MF59 adjuvanted trivalent influenza vaccine vs nonadjuvanted vaccines during the 2019–2020 influenza season
M Imran, J Puig-Barbera, JR Ortiz… - Open forum …, 2022 - academic.oup.com
Background Age-related immunosenescence may impair the immune response to
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …
[HTML][HTML] Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above …
R Hollingsworth, A Palmu, S Pepin, M Dupuy… - American Heart …, 2021 - Elsevier
Background Influenza has been an acknowledged cause of respiratory disease for decades.
However, considerable related, and often unappreciated, disease burden stems from …
However, considerable related, and often unappreciated, disease burden stems from …
High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults
AA Palmu, S Pepin, RK Syrjänen, K Mari… - Influenza and Other …, 2024 - Wiley Online Library
Background We assessed the relative vaccine effectiveness (rVE) of high‐dose quadrivalent
influenza vaccine (QIV‐HD) versus standard‐dose quadrivalent influenza vaccine (QIV‐SD) …
influenza vaccine (QIV‐HD) versus standard‐dose quadrivalent influenza vaccine (QIV‐SD) …
[PDF][PDF] Relative Effectiveness of MF59® Adjuvanted Trivalent Influenza Vaccine Versus Non-Adjuvanted Vaccines During the 2019-2020 Influenza Season
ESP Valencia - 2022 - researchgate.net
Background: Age-related immunosenescence may impair the immune response to
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …
[引用][C] Seqirus Presents Favorable Outcomes Data for Adjuvanted Trivalent Influenza Vaccine (FLUAD®) at 6th Annual IDWeek
IACSLBC Sites